The Galien Forum USA 2018


Sponsored by:

Panelist Bios

Cancer in a Time of Disruption

Over the past decade, we have witnessed a significant paradigm shift in the treatment of cancer, largely driven by the unprecedented pace of innovation and discovery in oncology. New advances in science, technology, and policy are improving patient outcomes while redefining how patients engage with the larger healthcare system. Despite this progress, however, major challenges remain in the areas of patient access, cost, coverage, combination therapies, resistance, and diagnostics, among others. This panel will examine critical issues around research, clinical, regulatory, and funding infrastructures and discuss potential solutions for creating a more flexible and technologically sophisticated framework for patient-centric drug development and treatment.